Filing Details
CTT PHARMACEUTICAL HOLDINGS, INC. (OTC:CTTH) filed a Form 8-K with the Securities and Exchange Commission on August 12, 2026, disclosing a material event.
8k filedOTC:CTTH
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) Reports Material Event to SEC
CTT PHARMACEUTICAL HOLDINGS, INC. (OTC:CTTH) filed a Form 8-K with the Securities and Exchange Commission on August 12, 2026, disclosing a material event.
At publication ·
What changed
CTT PHARMACEUTICAL HOLDINGS, INC. (OTC:CTTH) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- CTT Pharmaceutical Holdings, Inc. (CTTH) filed a Form 8-K with the SEC on August 12, 2026, disclosing a material event that shareholders should be aware of, though the specific nature of the event is not detailed in this filing notice.
- The company's stock trades at $0.07 per share with a market capitalization of $1.1 million as a healthcare company.
Market Context
CTT PHARMACEUTICAL HOLDINGS, INC.'s stock currently trades at $0.07 with a market capitalization of $1.1M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for CTT PHARMACEUTICAL HOLDINGS, INC.'s stock.
All SEC filings for CTT PHARMACEUTICAL HOLDINGS, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CTTH Stock Page
Frequently Asked Questions
Where can I read CTTH's SEC filings?
Browse all filings on our CTTH SEC filings page.
What types of SEC filings does CTT PHARMACEUTICAL HOLDINGS, INC. file?
Public companies like CTT PHARMACEUTICAL HOLDINGS, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.